103 results
Page 2 of 6
8-K
EX-10.1
5e4jm
17 Dec 20
Entry into a Material Definitive Agreement
4:05pm
424B3
bygr5i39r4 elpirpi
4 Dec 20
Prospectus supplement
4:48pm
8-K
EX-10.2
8pd6fzp3ez68mhmo2f
9 Sep 20
Seelos Therapeutics Announces Closing of $7.0 Million Registered Direct Offering
4:02pm
8-K
EX-10.1
g2eypcnqw79ur6z0mzy
9 Sep 20
Seelos Therapeutics Announces Closing of $7.0 Million Registered Direct Offering
4:02pm
424B5
73w5mb89vf05ylc9jt3
8 Sep 20
Prospectus supplement for primary offering
4:43pm
424B5
v2jawqt6g wl
12 Mar 20
Prospectus supplement for primary offering
5:27pm
8-K
EX-1.1
781zwsu2doh9u5
12 Mar 20
Seelos Therapeutics Announces Pricing of $4.5 Million Public Offering of Common Stock
5:24pm
8-K
EX-1.1
f7un febwrfyff06
11 Feb 20
Seelos Therapeutics Announces Pricing of $5 Million Public Offering of Common Stock
6:08am
424B5
h7e3puh qufm
3 Jan 20
Prospectus supplement for primary offering
4:32pm
424B3
fiwxxg4
2 Dec 19
Prospectus supplement
4:51pm
8-K
EX-10.2
0smq946d
27 Aug 19
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-10.1
0j614
27 Aug 19
Entry into a Material Definitive Agreement
4:31pm
424B5
h5ef6 qy8
23 Aug 19
Prospectus supplement for primary offering
7:45pm
8-K
EX-1.1
2x3og1ws nj72mij3y
17 Jun 19
Entry into a Material Definitive Agreement
9:55pm
424B5
1hy0nscvhzqij7tpyuzk
17 Jun 19
Prospectus supplement for primary offering
9:55pm
424B3
5awtuboc6h8
13 Feb 19
Prospectus supplement
4:45pm
424B3
veb21
13 Feb 19
Prospectus supplement
4:44pm